GAS-PHASE ELIMINATION IN SUBSTITUTED TRIAZOLINES AND ANALOGUES
329
4-Benzylidenimino-2-b-cyanoethyl-1,2,4-triazole-
4-Benzylideneimino-2-N-tetra-O-acetyl-b-D-glucosyl-
3(2H)-thione (5). Pale buff crystals, yield 89%, m.p. 112–
1,2,4-triazole-3(2H)-thione (9). Yield 50%, m.p. 192–
114°C. MS: m/z 257 (M ). IR: 3098, 2251, 751, 690 cmÀ1
.
193°C (lit.7 m.p. 193°C). MS: m/z 535 (M 1). IR: 3474,
1H NMR (CDCl3): ꢀ 3.02 (t, 2H, J = 6.9 Hz, CH2CN), 4.54
(t, 2H, J = 6.9 Hz, CH2N), 7.53 (m, 3H, ArH), 7.86 (m, 2H,
3151, 2976, 1751, 1611, 1547, 1427, 1365, 1235 cmÀ1
.
ArH), 8.11 (s, 1H, CH
=
N triazole), 10.40 (s, 1H,
4-p-Nitrobenzylideneimino-2-N-tetra-O-acetyl-b-D-
ArCH=
N). 13C NMR (CDCl3): ꢀ 16.8, 44.8, 117.0,
glucosyl-1,2,4-triazole-3(2H)-thione (10). Yield 55%,
129.2, 129.5, 132.5, 133.1, 140.0, 161.0, 161.9. Anal.
Calcd for C12H11N5S (257): C, 56.03; H, 4.28; N, 27.23;
S, 12.45. Found: C, 56.11; H, 4.28, N, 26.93; S, 12.89%.
m.p. 196–197°C. MS: m/z 580 (M 1). IR: 3400, 1751,
1593, 1525, 1425, 1365, 1349, 1233 cmÀ1 1H NMR
.
(CDCl3): ꢀ 1.97, 2.06, 2.09, 2.10 (4s, 12H, CH3), 4.02 (dd,
1H, CH-5'), 4.18, 4.25 (2 dd, 2H, CH2-6'), 5.28 (t, 1H, CH-
4'), 5.47 (t, 1H, CH-3'), 5.80 (t, 1H, CH-2'), 6.23 (d, 1H,
4-p-Nitrobenzylidenimino-2-b-cyanoethyl-1,2,4-tria-
zole-3(2H)-thione (6). Pale yellow crystals, yield 85%,
CH-1'), 8.04 (d, 2H, ArH), 8.11 (s, 1H, CH=N triazole),
m.p. 183–186°C. MS: m/z 302 (M ). IR: 3125, 2250,
8.35 (d, 2H, ArH), 10.92 (s, 1H, CH N). Anal. Calcd for
=
1594, 850, 771, 749 cmÀ1. H NMR (CDCl3): ꢀ 3.02 (t,
C23H25N5O11S (579): C, 47.67; H, 4.32; N, 12.09; S,
5.53. Found: C, 47.62; H, 4.16; N, 12.06; S, 5.35.
1
2H, J = 6.9 Hz, CH2CN), 4.55 (t, 2H, J = 6.9 Hz, CH2N),
8.04 (m, 2H, ArH), 8.06 (s, 1H, CH
(m, 2H, ArH), 10.92 (s, 1H, ArCH
=
=
N triazole), 8.35
N). 13C NMR
4-p-Methylbenzylideneimino-2-N-tetra-O-acetyl-b-D-
glucosyl-1,2,4-triazole-3(2H)-thione (11). Yield 50%,
(CDCl3): ꢀ 16.3, 44.2, 116.5, 124.2, 129.3, 138.2, 140.0,
149.9, 155.9, 161.4. Anal. Calcd for C12H10N6O2S (302):
C, 47.68; H, 3.31; N, 27.81; S, 10.59. Found: C, 48.05; H,
3.40, N, 27.41; S, 10.37%.
m.p. 217–218°C. MS: m/z 549 (M 1). IR: 1751, 1606,
1
1235 cmÀ1. H NMR (CDCl3): ꢀ 1.96, 2.06, 2.08, 2.10
(4s, 12H, CH3), 2.45 (s, 3H, ArCH3), 4.00 (m, 1H, CH-
5'), 4.20, 4.30 (2dd, 2H, CH2-6'), 5.27 (t, 1H, CH-4'), 5.44
(t, 1H, CH-3'), 5.80 (t, 1H, CH-2'), 6.25 (d, 1H, H-1'),
4-p-Methylbenzylidenimino-2-b-cyanoethyl-1,2,4-
triazole-3(2H)-thione (7). Colorless crystals, yield 88%,
7.30 (d, 2H, ArH), 7.75 (d, 2H, ArH), 8.07 (s, 1H, CH
=N
m.p. 150–151°C. MS: m/z 271 (M ). IR: 3083, 2251,
triazole), 10.25 (s, 1H, CH
=
N). 13C NMR(CDCl3): ꢀ
817, 753 cmÀ1. H NMR (CDCl3) ꢀ 2.46 (s, 3H, CH3),
21.0, 21.2, 22.2, 62.0, 68.1, 69.4, 74.0, 75.0, 82.0, 129.2,
129.7, 130.2, 140.3, 144.0, 161.6, 164.5, 169.4, 169.8,
170.6, 171.1. Anal. Calcd for C24H28N4O9S (548): C,
52.55; H, 5.11 N; 10.22; S, 5.84. Found: C, 52.75; H,
4.97; N, 10.31; S, 5.55.
1
3.00 (t, 2H, J = 6.9 Hz, CH2CN), 4.54 (t, 2H, J = 6.9 Hz,
CH2N), 7.35 (m, 2H, ArH), 7.79 (m, 2H, ArH), 8.09 (s,
1H, CH=N triazole), 10.28 (s, 1H, ArCH=
N). 13C NMR
(CDCl3): ꢀ 16.5, 21.8, 44.4, 116.6, 128.8, 129.7, 129.9,
139.4, 143.5, 161.0, 161.5. Anal. Calcd for C13H13N5S
(271): C, 57.56; H, 4.79; N, 25.83; S, 11.81. Found: C,
58.02; H, 4.89, N, 25.93; S, 12.08%.
4-p-Methoxybenzylideneimino-2-N-tetra-O-acetyl-b-
D-glucosyl-1,2,4-triazole-3(2H)-thione (12). Yield 50%,
m.p. 194–195°C (lit.6 m.p. 188°C). MS: m/z 564 (M ).
4-p-Methoxybenzylidenimino-2-b-cyanoethyl-1,2,4-
triazole-3(2H)-thione (8). White crystals, yield 82%,
IR: 3455, 3136, 2964, 2937, 2838, 1750, 1605, 1572,
1547, 1515, 1425, 1256, 1223 cmÀ1
.
m.p. 125–127°C. MS: m/z 287 (M ). IR: 3097, 3038,
2252, 819, 758 cmÀ1. H NMR (CDCl3): ꢀ 3.00 (t, 2H,
1
Acknowledgement
J = 6.9 Hz, CH2CN), 3.89 (s, 3H, OCH3), 4.53 (t, 2H,
J = 6.9 Hz, CH2N), 6.98 (m, 2H, ArH), 7.81 (m, 2H,
The support of the University of Kuwait received through
research grant (SC 03/00) and the facilities of ANALAB
and SAF are gratefully acknowledged.
ArH), 8.06 (s, 1H, CH
=N triazole), 10.11 (s, 1H,
ArCH=
N). 13C NMR (CDCl3): ꢀ 16.4, 44.4, 55.5, 114.5,
116.6, 124.5, 130.7, 139.2, 160.9, 163.3. Anal. Calcd for
C13H13N5OS (287): C, 54.36; H, 4.53; N, 24.39; S, 11.14.
Found: C, 54.17; H, 4.50, N, 24.21; S, 11.20%.
REFERENCES
1. Al-Awadi N, Ibrahim YA, Kaul K, Dib H. J. Phys. Org. Chem.
2001; 14: 521–525.
2. Al-Awadi N, Kaul K, El-Dusouqui O. Can. J. Chem. 1998; 76,
1922–1925.
3. Taylor R. J. Chem. Soc., Perkin Trans. 2 1983; 809–811.
4. Al-Awadi N, Elnagdi MH, Mathew T. Int. J. Chem. Kinet. 1995; 27,
517–523.
5. Holbrook KA. In The Chemistry of Acid Derivatives: Supplement B,
vol. 2, Patai S (ed). Wiley: Chichester, 1992; 703–745.
6. Al-Awadi N, Kaul K, EL-Dusouqui. J. Phys. Org. Chem. 2000; 13,
499–504.
Preparation of 2-N-glucosylbenzylideneamino-
1,2,4-triazoles. To a solution of the substituted benzy-
lidene aminotriazoles (5 mmol) in dimethylformamide
(5 ml) was added dry triethylamine (1 ml) and the solution
was stirred for 5 min. Acetobromoglucose (6 mmol) was
added and the solution was heated at 100° for 2 min and
stirred overnight. The precipitate formed upon dilution
with water was filtered and crystallized from ethanol to
afford crystals of the following compounds.
7. Ibrahim YA, Abbas AA, Elwahy AH. Carbohydr. Lett. 1999; 3,
331–338.
Copyright 2002 John Wiley & Sons, Ltd.
J. Phys. Org. Chem. 2002; 15: 324–329